204 related articles for article (PubMed ID: 34428130)
21. Caffeine dosing regimens in preterm infants with or at risk for apnea of prematurity.
Bruschettini M; Brattström P; Russo C; Onland W; Davis PG; Soll R
Cochrane Database Syst Rev; 2023 Apr; 4(4):CD013873. PubMed ID: 37040532
[TBL] [Abstract][Full Text] [Related]
22. Trends in Care Practices, Morbidity, and Mortality of Extremely Preterm Neonates, 1993-2012.
Stoll BJ; Hansen NI; Bell EF; Walsh MC; Carlo WA; Shankaran S; Laptook AR; Sánchez PJ; Van Meurs KP; Wyckoff M; Das A; Hale EC; Ball MB; Newman NS; Schibler K; Poindexter BB; Kennedy KA; Cotten CM; Watterberg KL; D'Angio CT; DeMauro SB; Truog WE; Devaskar U; Higgins RD;
JAMA; 2015 Sep; 314(10):1039-51. PubMed ID: 26348753
[TBL] [Abstract][Full Text] [Related]
23. The Diagnosis of Bronchopulmonary Dysplasia in Very Preterm Infants. An Evidence-based Approach.
Jensen EA; Dysart K; Gantz MG; McDonald S; Bamat NA; Keszler M; Kirpalani H; Laughon MM; Poindexter BB; Duncan AF; Yoder BA; Eichenwald EC; DeMauro SB
Am J Respir Crit Care Med; 2019 Sep; 200(6):751-759. PubMed ID: 30995069
[No Abstract] [Full Text] [Related]
24. Neonatal hematological parameters and the risk of moderate-severe bronchopulmonary dysplasia in extremely premature infants.
Chen X; Li H; Qiu X; Yang C; Walther FJ
BMC Pediatr; 2019 Apr; 19(1):138. PubMed ID: 31039810
[TBL] [Abstract][Full Text] [Related]
25. Comparisons and Limitations of Current Definitions of Bronchopulmonary Dysplasia for the Prematurity and Respiratory Outcomes Program.
Poindexter BB; Feng R; Schmidt B; Aschner JL; Ballard RA; Hamvas A; Reynolds AM; Shaw PA; Jobe AH;
Ann Am Thorac Soc; 2015 Dec; 12(12):1822-30. PubMed ID: 26397992
[TBL] [Abstract][Full Text] [Related]
26. Prolonged non-invasive ventilation in extremely low birth weight preterm infants is associated with bronchopulmonary dysplasia.
Chabra S; Strandjord T; Peeples E
J Neonatal Perinatal Med; 2019; 12(3):249-253. PubMed ID: 30932902
[TBL] [Abstract][Full Text] [Related]
27. Bronchopulmonary dysplasia: Rationale for a pathophysiological rather than treatment based approach to diagnosis.
Stoecklin B; Simpson SJ; Pillow JJ
Paediatr Respir Rev; 2019 Nov; 32():91-97. PubMed ID: 30745153
[TBL] [Abstract][Full Text] [Related]
28. Tidal Breathing Measurements at Discharge and Clinical Outcomes in Extremely Low Gestational Age Neonates.
Ren CL; Feng R; Davis SD; Eichenwald E; Jobe A; Moore PE; Panitch HB; Sharp JK; Kisling J; Clem C; Kemp JS
Ann Am Thorac Soc; 2018 Nov; 15(11):1311-1319. PubMed ID: 30088802
[TBL] [Abstract][Full Text] [Related]
29. Effect of Maternal Docosahexaenoic Acid Supplementation on Bronchopulmonary Dysplasia-Free Survival in Breastfed Preterm Infants: A Randomized Clinical Trial.
Marc I; Piedboeuf B; Lacaze-Masmonteil T; Fraser W; Mâsse B; Mohamed I; Qureshi M; Afifi J; Lemyre B; Caouette G; Bartholomew J; Nuyt AM; Julien P; Synnes A; Lucas M; Perreault T; Strueby L; Cieslak Z; Yusuf K; Pelligra G; Massé E; Larsen B; de Cabo C; Ruth C; Khurshid F; Lavoie PM
JAMA; 2020 Jul; 324(2):157-167. PubMed ID: 32662862
[TBL] [Abstract][Full Text] [Related]
30. Cerebral Oximetry Monitoring in Extremely Preterm Infants.
Hansen ML; Pellicer A; Hyttel-Sørensen S; Ergenekon E; Szczapa T; Hagmann C; Naulaers G; Mintzer J; Fumagalli M; Dimitriou G; Dempsey E; Tkaczyk J; Cheng G; Fredly S; Heuchan AM; Pichler G; Fuchs H; Nesargi S; Hahn GH; Piris-Borregas S; Širc J; Alsina-Casanova M; Stocker M; Ozkan H; Sarafidis K; Hopper AO; Karen T; Rzepecka-Weglarz B; Oguz SS; Arruza L; Memisoglu AC; Del Rio Florentino R; Baserga M; Maton P; Truttmann AC; de Las Cuevas I; Agergaard P; Zafra P; Bender L; Lauterbach R; Lecart C; de Buyst J; El-Khuffash A; Curley A; Vaccarello OO; Miletin J; Papathoma E; Vesoulis Z; Vento G; Cornette L; Lopez LS; Yasa B; Klamer A; Agosti M; Baud O; Mastretta E; Cetinkaya M; McCall K; Zeng S; Hatzidaki E; Bargiel A; Marciniak S; Gao X; Huijia L; Chalak L; Yang L; Rao SA; Xu X; Gonzalez BL; Wilinska M; Yin Z; Sadowska-Krawczenko I; Serrano-Viñuales I; Krolak-Olejnik B; Ybarra MM; Morales-Betancourt C; Korček P; Teresa-Palacio M; Mosca F; Hergenhan A; Koksal N; Tsoni K; Kadri MM; Knöpfli C; Rafinska-Wazny E; Akin MS; Nordvik T; Peng Z; Kersin SG; Thewissen L; Alarcon A; Healy D; Urlesberger B; Baş M; Baumgartner J; Skylogianni E; Karadyova V; Valverde E; Bergon-Sendin E; Kucera J; Pisoni S; Wang L; Smits A; Sanchez-Salmador R; Rasmussen MI; Olsen MH; Jensen AK; Gluud C; Jakobsen JC; Greisen G
N Engl J Med; 2023 Apr; 388(16):1501-1511. PubMed ID: 37075142
[TBL] [Abstract][Full Text] [Related]
31. Soluble vascular endothelial growth factor receptor 1 in tracheal aspirate fluid of preterm neonates at birth may be predictive of bronchopulmonary dysplasia/chronic lung disease.
Hasan J; Beharry KD; Valencia AM; Strauss A; Modanlou HD
Pediatrics; 2009 Jun; 123(6):1541-7. PubMed ID: 19482766
[TBL] [Abstract][Full Text] [Related]
32. "New" bronchopulmonary dysplasia and chronic lung disease.
Voynow JA
Paediatr Respir Rev; 2017 Sep; 24():17-18. PubMed ID: 28697967
[TBL] [Abstract][Full Text] [Related]
33. Superoxide dismutase for bronchopulmonary dysplasia in preterm infants.
Albertella M; Gentyala RR; Paraskevas T; Ehret D; Bruschettini M; Soll R
Cochrane Database Syst Rev; 2023 Oct; 10(10):CD013232. PubMed ID: 37811631
[TBL] [Abstract][Full Text] [Related]
34. Intratracheal budesonide mixed with surfactant to increase survival free of bronchopulmonary dysplasia in extremely preterm infants: statistical analysis plan for the international, multicenter, randomized PLUSS trial.
Francis KL; McKinlay CJD; Kamlin COF; Cheong JLY; Dargaville PA; Dawson JA; Doyle LW; Jacobs SE; Davis PG; Donath SM; Manley BJ
Trials; 2023 Nov; 24(1):709. PubMed ID: 37932774
[TBL] [Abstract][Full Text] [Related]
35. Preeclampsia and risk of developing bronchopulmonary dysplasia in very preterm neonates.
Wilmink FA; Reijnierse J; Reiss IKM; Steegers EAP; de Jonge RCJ;
Pregnancy Hypertens; 2019 Jan; 15():57-63. PubMed ID: 30825928
[TBL] [Abstract][Full Text] [Related]
36. Effectiveness of Nasal Continuous Positive Airway Pressure vs Nasal Intermittent Positive Pressure Ventilation vs Noninvasive High-Frequency Oscillatory Ventilation as Support After Extubation of Neonates Born Extremely Preterm or With More Severe Respiratory Failure: A Secondary Analysis of a Randomized Clinical Trial.
Zhu X; Li F; Shi Y; Feng Z; De Luca D;
JAMA Netw Open; 2023 Jul; 6(7):e2321644. PubMed ID: 37399009
[TBL] [Abstract][Full Text] [Related]
37. High-frequency oscillatory ventilation versus synchronized intermittent mandatory ventilation plus pressure support in preterm infants with severe respiratory distress syndrome.
Sun H; Cheng R; Kang W; Xiong H; Zhou C; Zhang Y; Wang X; Zhu C
Respir Care; 2014 Feb; 59(2):159-69. PubMed ID: 23764865
[TBL] [Abstract][Full Text] [Related]
38. Low caloric intake and high fluid intake during the first week of life are associated with the severity of bronchopulmonary dysplasia in extremely low birth weight infants.
Al-Jebawi Y; Agarwal N; Groh Wargo S; Shekhawat P; Mhanna MJ
J Neonatal Perinatal Med; 2020; 13(2):207-214. PubMed ID: 31771083
[TBL] [Abstract][Full Text] [Related]
39. Lung Ultrasound to Monitor Extremely Preterm Infants and Predict Bronchopulmonary Dysplasia. A Multicenter Longitudinal Cohort Study.
Loi B; Vigo G; Baraldi E; Raimondi F; Carnielli VP; Mosca F; De Luca D
Am J Respir Crit Care Med; 2021 Jun; 203(11):1398-1409. PubMed ID: 33352083
[No Abstract] [Full Text] [Related]
40. Late (≥ 7 days) inhaled corticosteroids to reduce bronchopulmonary dysplasia in preterm infants.
Onland W; Offringa M; van Kaam A
Cochrane Database Syst Rev; 2022 Dec; 12(12):CD002311. PubMed ID: 36521169
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
